0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fulvestrant Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-18K14910
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Fulvestrant Injection Market Research Report 2023
BUY CHAPTERS

Global Fulvestrant Injection Market Research Report 2025

Code: QYRE-Auto-18K14910
Report
May 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Fulvestrant Injection Market

The global market for Fulvestrant Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Fulvestrant Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Fulvestrant Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Fulvestrant Injection include AstraZeneca, Sichuan Huiyu Pharmaceutical Co., Ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Corporation, Hansoh Pharmaceutical Group Company Limited, Qilu Pharmaceutical, Vetter Pharma-Fertigung GmbH & Co. KG, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Sandoz, Hikma Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fulvestrant Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fulvestrant Injection.
The Fulvestrant Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fulvestrant Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fulvestrant Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Fulvestrant Injection Market Report

Report Metric Details
Report Name Fulvestrant Injection Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Sichuan Huiyu Pharmaceutical Co., Ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Corporation, Hansoh Pharmaceutical Group Company Limited, Qilu Pharmaceutical, Vetter Pharma-Fertigung GmbH & Co. KG, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Sandoz, Hikma Pharmaceuticals, Teva Pharmaceuticals, Eugia US, Xiromed LLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Fulvestrant Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Fulvestrant Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Fulvestrant Injection Market report?

Ans: The main players in the Fulvestrant Injection Market are AstraZeneca, Sichuan Huiyu Pharmaceutical Co., Ltd., Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group Corporation, Hansoh Pharmaceutical Group Company Limited, Qilu Pharmaceutical, Vetter Pharma-Fertigung GmbH & Co. KG, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Sandoz, Hikma Pharmaceuticals, Teva Pharmaceuticals, Eugia US, Xiromed LLC

What are the Application segmentation covered in the Fulvestrant Injection Market report?

Ans: The Applications covered in the Fulvestrant Injection Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Fulvestrant Injection Market report?

Ans: The Types covered in the Fulvestrant Injection Market report are Original Drugs, Generic Drugs

Recommended Reports

Injection Drug Markets

Drug Delivery Devices

Therapeutic Agents

1 Fulvestrant Injection Market Overview
1.1 Product Definition
1.2 Fulvestrant Injection by Type
1.2.1 Global Fulvestrant Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Original Drugs
1.2.3 Generic Drugs
1.3 Fulvestrant Injection by Application
1.3.1 Global Fulvestrant Injection Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Fulvestrant Injection Market Size Estimates and Forecasts
1.4.1 Global Fulvestrant Injection Revenue 2020-2031
1.4.2 Global Fulvestrant Injection Sales 2020-2031
1.4.3 Global Fulvestrant Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Fulvestrant Injection Market Competition by Manufacturers
2.1 Global Fulvestrant Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Fulvestrant Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Fulvestrant Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Fulvestrant Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fulvestrant Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fulvestrant Injection, Product Type & Application
2.7 Global Key Manufacturers of Fulvestrant Injection, Date of Enter into This Industry
2.8 Global Fulvestrant Injection Market Competitive Situation and Trends
2.8.1 Global Fulvestrant Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Fulvestrant Injection Players Market Share by Revenue
2.8.3 Global Fulvestrant Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Fulvestrant Injection Market Scenario by Region
3.1 Global Fulvestrant Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Fulvestrant Injection Sales by Region: 2020-2031
3.2.1 Global Fulvestrant Injection Sales by Region: 2020-2025
3.2.2 Global Fulvestrant Injection Sales by Region: 2026-2031
3.3 Global Fulvestrant Injection Revenue by Region: 2020-2031
3.3.1 Global Fulvestrant Injection Revenue by Region: 2020-2025
3.3.2 Global Fulvestrant Injection Revenue by Region: 2026-2031
3.4 North America Fulvestrant Injection Market Facts & Figures by Country
3.4.1 North America Fulvestrant Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Fulvestrant Injection Sales by Country (2020-2031)
3.4.3 North America Fulvestrant Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fulvestrant Injection Market Facts & Figures by Country
3.5.1 Europe Fulvestrant Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Fulvestrant Injection Sales by Country (2020-2031)
3.5.3 Europe Fulvestrant Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fulvestrant Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Fulvestrant Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Fulvestrant Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Fulvestrant Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Fulvestrant Injection Market Facts & Figures by Country
3.7.1 Latin America Fulvestrant Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Fulvestrant Injection Sales by Country (2020-2031)
3.7.3 Latin America Fulvestrant Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fulvestrant Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Fulvestrant Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Fulvestrant Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Fulvestrant Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fulvestrant Injection Sales by Type (2020-2031)
4.1.1 Global Fulvestrant Injection Sales by Type (2020-2025)
4.1.2 Global Fulvestrant Injection Sales by Type (2026-2031)
4.1.3 Global Fulvestrant Injection Sales Market Share by Type (2020-2031)
4.2 Global Fulvestrant Injection Revenue by Type (2020-2031)
4.2.1 Global Fulvestrant Injection Revenue by Type (2020-2025)
4.2.2 Global Fulvestrant Injection Revenue by Type (2026-2031)
4.2.3 Global Fulvestrant Injection Revenue Market Share by Type (2020-2031)
4.3 Global Fulvestrant Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Fulvestrant Injection Sales by Application (2020-2031)
5.1.1 Global Fulvestrant Injection Sales by Application (2020-2025)
5.1.2 Global Fulvestrant Injection Sales by Application (2026-2031)
5.1.3 Global Fulvestrant Injection Sales Market Share by Application (2020-2031)
5.2 Global Fulvestrant Injection Revenue by Application (2020-2031)
5.2.1 Global Fulvestrant Injection Revenue by Application (2020-2025)
5.2.2 Global Fulvestrant Injection Revenue by Application (2026-2031)
5.2.3 Global Fulvestrant Injection Revenue Market Share by Application (2020-2031)
5.3 Global Fulvestrant Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Fulvestrant Injection Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Sichuan Huiyu Pharmaceutical Co., Ltd.
6.2.1 Sichuan Huiyu Pharmaceutical Co., Ltd. Company Information
6.2.2 Sichuan Huiyu Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Sichuan Huiyu Pharmaceutical Co., Ltd. Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sichuan Huiyu Pharmaceutical Co., Ltd. Fulvestrant Injection Product Portfolio
6.2.5 Sichuan Huiyu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd.
6.3.1 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
6.3.2 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Fulvestrant Injection Product Portfolio
6.3.5 Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Lunan Pharmaceutical Group Corporation
6.4.1 Lunan Pharmaceutical Group Corporation Company Information
6.4.2 Lunan Pharmaceutical Group Corporation Description and Business Overview
6.4.3 Lunan Pharmaceutical Group Corporation Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lunan Pharmaceutical Group Corporation Fulvestrant Injection Product Portfolio
6.4.5 Lunan Pharmaceutical Group Corporation Recent Developments/Updates
6.5 Hansoh Pharmaceutical Group Company Limited
6.5.1 Hansoh Pharmaceutical Group Company Limited Company Information
6.5.2 Hansoh Pharmaceutical Group Company Limited Description and Business Overview
6.5.3 Hansoh Pharmaceutical Group Company Limited Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hansoh Pharmaceutical Group Company Limited Fulvestrant Injection Product Portfolio
6.5.5 Hansoh Pharmaceutical Group Company Limited Recent Developments/Updates
6.6 Qilu Pharmaceutical
6.6.1 Qilu Pharmaceutical Company Information
6.6.2 Qilu Pharmaceutical Description and Business Overview
6.6.3 Qilu Pharmaceutical Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Qilu Pharmaceutical Fulvestrant Injection Product Portfolio
6.6.5 Qilu Pharmaceutical Recent Developments/Updates
6.7 Vetter Pharma-Fertigung GmbH & Co. KG
6.7.1 Vetter Pharma-Fertigung GmbH & Co. KG Company Information
6.7.2 Vetter Pharma-Fertigung GmbH & Co. KG Description and Business Overview
6.7.3 Vetter Pharma-Fertigung GmbH & Co. KG Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Vetter Pharma-Fertigung GmbH & Co. KG Fulvestrant Injection Product Portfolio
6.7.5 Vetter Pharma-Fertigung GmbH & Co. KG Recent Developments/Updates
6.8 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
6.8.1 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Company Information
6.8.2 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Fulvestrant Injection Product Portfolio
6.8.5 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Sandoz
6.9.1 Sandoz Company Information
6.9.2 Sandoz Description and Business Overview
6.9.3 Sandoz Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sandoz Fulvestrant Injection Product Portfolio
6.9.5 Sandoz Recent Developments/Updates
6.10 Hikma Pharmaceuticals
6.10.1 Hikma Pharmaceuticals Company Information
6.10.2 Hikma Pharmaceuticals Description and Business Overview
6.10.3 Hikma Pharmaceuticals Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hikma Pharmaceuticals Fulvestrant Injection Product Portfolio
6.10.5 Hikma Pharmaceuticals Recent Developments/Updates
6.11 Teva Pharmaceuticals
6.11.1 Teva Pharmaceuticals Company Information
6.11.2 Teva Pharmaceuticals Description and Business Overview
6.11.3 Teva Pharmaceuticals Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Teva Pharmaceuticals Fulvestrant Injection Product Portfolio
6.11.5 Teva Pharmaceuticals Recent Developments/Updates
6.12 Eugia US
6.12.1 Eugia US Company Information
6.12.2 Eugia US Description and Business Overview
6.12.3 Eugia US Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Eugia US Fulvestrant Injection Product Portfolio
6.12.5 Eugia US Recent Developments/Updates
6.13 Xiromed LLC
6.13.1 Xiromed LLC Company Information
6.13.2 Xiromed LLC Description and Business Overview
6.13.3 Xiromed LLC Fulvestrant Injection Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Xiromed LLC Fulvestrant Injection Product Portfolio
6.13.5 Xiromed LLC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fulvestrant Injection Industry Chain Analysis
7.2 Fulvestrant Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fulvestrant Injection Production Mode & Process Analysis
7.4 Fulvestrant Injection Sales and Marketing
7.4.1 Fulvestrant Injection Sales Channels
7.4.2 Fulvestrant Injection Distributors
7.5 Fulvestrant Injection Customer Analysis
8 Fulvestrant Injection Market Dynamics
8.1 Fulvestrant Injection Industry Trends
8.2 Fulvestrant Injection Market Drivers
8.3 Fulvestrant Injection Market Challenges
8.4 Fulvestrant Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Fulvestrant Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Fulvestrant Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Fulvestrant Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Fulvestrant Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Fulvestrant Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Fulvestrant Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Fulvestrant Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Fulvestrant Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Fulvestrant Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Fulvestrant Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Fulvestrant Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Fulvestrant Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Fulvestrant Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fulvestrant Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Fulvestrant Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Fulvestrant Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Fulvestrant Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Fulvestrant Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Fulvestrant Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Fulvestrant Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Fulvestrant Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Fulvestrant Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Fulvestrant Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Fulvestrant Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Fulvestrant Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Fulvestrant Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Fulvestrant Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Fulvestrant Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Fulvestrant Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Fulvestrant Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Fulvestrant Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Fulvestrant Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Fulvestrant Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Fulvestrant Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Fulvestrant Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Fulvestrant Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Fulvestrant Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Fulvestrant Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Fulvestrant Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Fulvestrant Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Fulvestrant Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Fulvestrant Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Fulvestrant Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Fulvestrant Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Fulvestrant Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Fulvestrant Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Fulvestrant Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Fulvestrant Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Fulvestrant Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Fulvestrant Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Fulvestrant Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Fulvestrant Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Fulvestrant Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Fulvestrant Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Fulvestrant Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Fulvestrant Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Fulvestrant Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Fulvestrant Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Fulvestrant Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Fulvestrant Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Fulvestrant Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Fulvestrant Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Fulvestrant Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Fulvestrant Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Fulvestrant Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Fulvestrant Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Fulvestrant Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Fulvestrant Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Fulvestrant Injection Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Sichuan Huiyu Pharmaceutical Co., Ltd. Company Information
 Table 76. Sichuan Huiyu Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Sichuan Huiyu Pharmaceutical Co., Ltd. Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sichuan Huiyu Pharmaceutical Co., Ltd. Fulvestrant Injection Product
 Table 79. Sichuan Huiyu Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Company Information
 Table 81. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Fulvestrant Injection Product
 Table 84. Jiangsu Chia Tai-Tianqing Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Lunan Pharmaceutical Group Corporation Company Information
 Table 86. Lunan Pharmaceutical Group Corporation Description and Business Overview
 Table 87. Lunan Pharmaceutical Group Corporation Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Lunan Pharmaceutical Group Corporation Fulvestrant Injection Product
 Table 89. Lunan Pharmaceutical Group Corporation Recent Developments/Updates
 Table 90. Hansoh Pharmaceutical Group Company Limited Company Information
 Table 91. Hansoh Pharmaceutical Group Company Limited Description and Business Overview
 Table 92. Hansoh Pharmaceutical Group Company Limited Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Hansoh Pharmaceutical Group Company Limited Fulvestrant Injection Product
 Table 94. Hansoh Pharmaceutical Group Company Limited Recent Developments/Updates
 Table 95. Qilu Pharmaceutical Company Information
 Table 96. Qilu Pharmaceutical Description and Business Overview
 Table 97. Qilu Pharmaceutical Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Qilu Pharmaceutical Fulvestrant Injection Product
 Table 99. Qilu Pharmaceutical Recent Developments/Updates
 Table 100. Vetter Pharma-Fertigung GmbH & Co. KG Company Information
 Table 101. Vetter Pharma-Fertigung GmbH & Co. KG Description and Business Overview
 Table 102. Vetter Pharma-Fertigung GmbH & Co. KG Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Vetter Pharma-Fertigung GmbH & Co. KG Fulvestrant Injection Product
 Table 104. Vetter Pharma-Fertigung GmbH & Co. KG Recent Developments/Updates
 Table 105. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Company Information
 Table 106. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Description and Business Overview
 Table 107. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Fulvestrant Injection Product
 Table 109. Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 110. Sandoz Company Information
 Table 111. Sandoz Description and Business Overview
 Table 112. Sandoz Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Sandoz Fulvestrant Injection Product
 Table 114. Sandoz Recent Developments/Updates
 Table 115. Hikma Pharmaceuticals Company Information
 Table 116. Hikma Pharmaceuticals Description and Business Overview
 Table 117. Hikma Pharmaceuticals Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Hikma Pharmaceuticals Fulvestrant Injection Product
 Table 119. Hikma Pharmaceuticals Recent Developments/Updates
 Table 120. Teva Pharmaceuticals Company Information
 Table 121. Teva Pharmaceuticals Description and Business Overview
 Table 122. Teva Pharmaceuticals Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Teva Pharmaceuticals Fulvestrant Injection Product
 Table 124. Teva Pharmaceuticals Recent Developments/Updates
 Table 125. Eugia US Company Information
 Table 126. Eugia US Description and Business Overview
 Table 127. Eugia US Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Eugia US Fulvestrant Injection Product
 Table 129. Eugia US Recent Developments/Updates
 Table 130. Xiromed LLC Company Information
 Table 131. Xiromed LLC Description and Business Overview
 Table 132. Xiromed LLC Fulvestrant Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Xiromed LLC Fulvestrant Injection Product
 Table 134. Xiromed LLC Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Fulvestrant Injection Distributors List
 Table 138. Fulvestrant Injection Customers List
 Table 139. Fulvestrant Injection Market Trends
 Table 140. Fulvestrant Injection Market Drivers
 Table 141. Fulvestrant Injection Market Challenges
 Table 142. Fulvestrant Injection Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Fulvestrant Injection
 Figure 2. Global Fulvestrant Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Fulvestrant Injection Market Share by Type: 2024 & 2031
 Figure 4. Original Drugs Product Picture
 Figure 5. Generic Drugs Product Picture
 Figure 6. Global Fulvestrant Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Fulvestrant Injection Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Fulvestrant Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Fulvestrant Injection Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Fulvestrant Injection Sales (2020-2031) & (K Units)
 Figure 14. Global Fulvestrant Injection Average Price (US$/Unit) & (2020-2031)
 Figure 15. Fulvestrant Injection Report Years Considered
 Figure 16. Fulvestrant Injection Sales Share by Manufacturers in 2024
 Figure 17. Global Fulvestrant Injection Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Fulvestrant Injection Players: Market Share by Revenue in Fulvestrant Injection in 2024
 Figure 19. Fulvestrant Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Fulvestrant Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Fulvestrant Injection Sales Market Share by Country (2020-2031)
 Figure 22. North America Fulvestrant Injection Revenue Market Share by Country (2020-2031)
 Figure 23. United States Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Fulvestrant Injection Sales Market Share by Country (2020-2031)
 Figure 26. Europe Fulvestrant Injection Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Fulvestrant Injection Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Fulvestrant Injection Revenue Market Share by Region (2020-2031)
 Figure 34. China Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Fulvestrant Injection Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Fulvestrant Injection Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Fulvestrant Injection Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Fulvestrant Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Fulvestrant Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Fulvestrant Injection by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Fulvestrant Injection by Type (2020-2031)
 Figure 53. Global Fulvestrant Injection Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Fulvestrant Injection by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Fulvestrant Injection by Application (2020-2031)
 Figure 56. Global Fulvestrant Injection Price (US$/Unit) by Application (2020-2031)
 Figure 57. Fulvestrant Injection Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart